- Home
- ALT vs GPRK Comparison
ALT vs GPRK Comparison
Compare ALT & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | GPRK |
|---|---|---|
| Founded | 1997 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 397.8M |
| IPO Year | 2005 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ALT | GPRK |
|---|---|---|
| Price | $3.12 | $8.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $17.67 | $8.50 |
| AVG Volume (30 Days) | ★ 3.2M | 1.4M |
| Earning Date | 03-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | $39.45 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.87 | $5.66 |
| 52 Week High | $7.73 | $10.34 |
Technical Indicators
Market Signals| Indicator | ALT | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 36.04 | 44.46 |
| Support Level | $2.91 | $7.84 |
| Resistance Level | $4.25 | $9.09 |
| Average True Range (ATR) | 0.17 | 0.46 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 29.17 | 6.96 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.